Drugs / undecavalent pneumococcal-protein D conjugate vaccine
undecavalent pneumococcal-protein D conjugate vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00119743 | Oct 2000 → Jun 2004 | hepatitis A virus infection | GlaxoSmithKline | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | undecavalent pneumococcal-protein D conjugate vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00119743 ↗ |
| Modality | Vaccine | “undecavalent pneumococcal-protein D conjugate vaccine” NCT00119743 ↗ |